Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone

Drug Saf. 2018 Oct;41(10):979-980. doi: 10.1007/s40264-018-0705-8.

Ingrid A Binswanger^{1

2

3}, Jason M Glanz^{4

5}

¹ Institute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO, 80237-8066, USA. [email protected].
² Colorado Permanente Medical Group, Aurora, CO, USA. [email protected].
³ Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA. [email protected].
⁴ Institute for Health Research, Kaiser Permanente Colorado, PO Box 378066, Denver, CO, 80237-8066, USA.
⁵ Colorado School of Public Health, Aurora, CO, USA.

No abstract available

Publication types